Skip to main content

COVID-19 pandemic: An innovative, safe and effective bio-decontamination technology for non-toxic removal of biological agents, including coronavirus

Project description

An innovative decontamination product against COVID-19

Most decontaminating agents against pathogens such as COVID-19 or influenza virus are based on chemicals that cannot be used repeatedly on skin as they may lead to health complications. The EU-funded ABwipe project is developing a unique product that exploits the mechanism of pathogen binding. Based on a cellulose matrix, it contains carbohydrate–protein binders with a strong affinity for pandemic agents such as influenza and coronavirus. Apart from its disinfectant capacity, which has the potential to impede infection spread, the ABwipe material can be used in forensics and diagnostics for pathogen identification.

Field of science

  • /medical and health sciences/health sciences/epidemiology/pandemics
  • /medical and health sciences/health sciences/infectious disease/RNA virus/coronavirus

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

AQUILA BIOSCIENCE LIMITED
Address
Ballinahalla
Moycullen Galway
Ireland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 1 940 968,75